Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| NKD-H82Q3 | Human | Biotinylated Human NKG2D / CD314 Protein, Avitag™,His Tag (MALS verified) |  |
|
|
| NKD-C5248 | Cynomolgus | Cynomolgus NKG2D / CD314 Protein, His Tag |  |
|
|
| NKD-H5257 | Human | Human NKG2D / CD314 Protein, Llama IgG2b Fc Tag, low endotoxin |  |
|
|
| NKD-H82F4 | Human | Biotinylated Human NKG2D / CD314 Protein, Avitag™,Fc Tag (MALS verified) |  |
|
|
| NKD-HF224 | Human | FITC-Labeled Human NKG2D / CD314 Protein, Fc Tag |  |
|
|
| NKD-H5259 | Human | Human NKG2D / CD314 Protein, Mouse IgG2a Fc Tag |  |
|
|
| NKD-H5245 | Human | Human NKG2D / CD314 Protein, His Tag |  |
|
|
| NKD-H5265 | Human | Human NKG2D / CD314 Protein, Fc Tag (HPLC-verified) |  |
|
|
Immobilized Cynomolgus NKG2D, His Tag (Cat. No. NKD-C5248) at 5 μg/mL (100 μL/well) can bind Human MICA, Fc Tag (Cat. No. MIA-H5253) with a linear range of 0.2-2 ng/mL (QC tested).
The purity of Biotinylated Human NKG2D Protein, Avitag,His Tag (Cat. No. NKD-H82Q3) is more than 85% and the molecular weight of this protein is around 36-46 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Tesnatilimab | IPH-2301; IPH-23XX; JNJ-4500; JNJ-64304500; NNC-0142-002; NNC-0142-0002; NNC-0142-0000-0002; NN-8555 | Phase 2 Clinical | Innate Pharma | Alopecia Areata; Arthritis, Rheumatoid; Celiac Disease; Inflammation; Crohn Disease | Details |
| QEQ-278 | QEQ-278 | Phase 1 Clinical | Novartis Pharmaceuticals Corp | Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Esophageal Squamous Cell Carcinoma; Carcinoma, Non-Small-Cell Lung | Details |
| NKG2D CAR-T Cell therapy (Yake Biotechnology) | Phase 1 Clinical | Shanghai YaKe Biotechnology Co Ltd | Colorectal Neoplasms; Leukemia, Myeloid, Acute | Details | |
| Anti-NKG2D chimeric antigen receptor natural killer cell therapy (Hangzhou Cheetah Cell Therapeutics) | Clinical | Ovarian Neoplasms; Leukemia, Myeloid, Acute | Details | ||
| NKG2D CAR-T cell therapy (Uwell Biopharma) | UWN2D | Clinical | Uwell Biopharma | Neoplasms | Details |
This web search service is supported by Google Inc.
A-Z
